EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

IVF patient subgroups benefit from preimplantation genetic testing for aneuploidy: a prospective multicentre cohort study

Sofie L Møller, Maria Borgstrøm, Johnny Hindkjær, Ulrik S Kesmodel, Jeanette Bogstad, Majbritt B Madsen, Daniela Alosi, Morten R Petersen, Jørn Aagaard, Aboubakar Cissé, Kristina W Olsen, Laura Ks Roos und 5 weitere

Reproductive BioMedicine Online · 2026

DOI: 10.1016/j.rbmo.2026.105776 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Reproductive BioMedicine Online, 2026. Verfasst von Sofie L Møller und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Fertility Clinic, Copenhagen University Hospital Herlev, Herlev, Denmark. Hauptthemen laut MEDLINE: Aneuploidy, Fertilization in Vitro, Genetic Testing, Preimplantation Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck, Capital Region of Denmark, Gedeon Richter.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: Can preimplantation genetic testing for aneuploidy (PGT-A) improve the ongoing pregnancy rate per transfer and reduce miscarriage rate in patients with advanced maternal age (AMA), recurrent implantation failure (RIF), recurrent pregnancy loss (RPL), or both, without affecting cumulative pregnancy rate? DESIGN: Prospective cohort study of 260 patients undergoing PGT-A aged 36 years or over (AMA group), with a history of three or more blastocyst transfers without birth (RIF group), two or more early pregnancy losses (RPL group), or all. Trophectoderm biopsy was conducted day 5 or 6, and comprehensive chromosome screening was used for PGT-A before single frozen embryo transfer (PGT-A-FET). A total of 3060 patients undergoing single conventional frozen embryo transfer (FET) served as a historical reference group. RESULTS: Patients had increased odds of positive serum beta-HCG after PGT-A-FET compared with FET in the AMA (OR 1.53, 95% CI 1.06 to 2.21) and RIF (OR 2.11, 95% CI 1.41 to 3.14) groups. The PGT-A-FET group significantly improved the odds of ongoing pregnancy in the AMA (OR 2.20, 95% CI 1.52 to 3.18), RIF (OR 3.96, 95% CI 2.60 to 6.04) and RPL (OR 2.81, 95% CI 1.52 to 5.21) groups. The odds of pregnancy loss were significantly reduced with PGT-A-FET in the AMA (OR 0.36, 95% CI 0.21 to 0.64), RIF (OR 0.10, 95% CI 0.04 to 0.26) and RPL (OR 0.14, 95% CI 0.04 to 0.53) groups. Cumulative pregnancy rate did not differ between PGT-A and conventional cycles (RR 0.94, 95% CI 0.80 to 1.10). CONCLUSIONS: PGT-A improved the odds of ongoing pregnancy and reduced the odds of pregnancy loss in all groups. The cumulative pregnancy rate did not differ between PGT-A and conventional cycles. Findings should be interpreted in the context of the observational design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AneuploidyFertilization in VitroGenetic TestingPreimplantation DiagnosisAdultFemaleHumansPregnancyAbortion, HabitualAdvanced Maternal AgeCohort StudiesEmbryo TransferMaternal AgePregnancy RateProspective Studies

Stichwörter der Autor:innen

AMAFETPGT-ARIFRPL

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Fertility Clinic, Copenhagen University Hospital Herlev, Herlev, Denmark.
  • Aagaard Fertility Clinic, Aarhus, Denmark.
  • Department of Obstetrics and Gynecology, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Gynecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Center for Genomic Medicine, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Denmark.

Förderung

  • Merck
  • Capital Region of Denmark
  • Gedeon Richter

Zitieren

APA

Møller, S. L., Borgstrøm, M., Hindkjær, J., Kesmodel, U. S., Bogstad, J., Madsen, M. B., Alosi, D., Petersen, M. R., Aagaard, J., Cissé, A., Olsen, K. W., Roos, L. K., Hertz, J. M., Madsen, K., Klajnbard, A., Nøhr, B., & Grøndahl, M. L. (2026). IVF patient subgroups benefit from preimplantation genetic testing for aneuploidy: a prospective multicentre cohort study. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2026.105776

Vancouver

Møller SL, Borgstrøm M, Hindkjær J, Kesmodel US, Bogstad J, Madsen MB, et al. IVF patient subgroups benefit from preimplantation genetic testing for aneuploidy: a prospective multicentre cohort study. Reproductive BioMedicine Online. 2026. doi:10.1016/j.rbmo.2026.105776

BibTeX
@article{Mller2026,
  author = {Møller, Sofie L and Borgstrøm, Maria and Hindkjær, Johnny and Kesmodel, Ulrik S and Bogstad, Jeanette and Madsen, Majbritt B and Alosi, Daniela and Petersen, Morten R and Aagaard, Jørn and Cissé, Aboubakar and Olsen, Kristina W and Roos, Laura Ks and Hertz, Jens M and Madsen, Kasper and Klajnbard, Anna and Nøhr, Bugge and Grøndahl, Marie L},
  title = {IVF patient subgroups benefit from preimplantation genetic testing for aneuploidy: a prospective multicentre cohort study},
  journal = {Reproductive BioMedicine Online},
  year = {2026},
  doi = {10.1016/j.rbmo.2026.105776}
}
Kostenlos starten →